About the Company
mannkind corporation (nasdaq: mnkd) focuses on the discovery, development and commercialization of therapeutic products for patients with diseases such as diabetes and cancer. in addition, mannkind is applying our novel technologies and services to support partner development efforts.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $MNKD News
What's Going On With MannKind Stock?
MannKind Corporation (NASDAQ:MNKD) shares are trending on social media Monday. Here's a look at what's going on. What To Know ...
MannKind Corporation: Strong Growth and Clinical Advancements Prompt Buy Rating
MannKind (MNKD – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Andreas Argyrides ...
Cramer Says Sprout Social Is In A 'Hot Spot,' But This Energy Stock Is 'Too Down And Out'
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he needs to do more work on Sprout Social, Inc. (NASDAQ: SPT) as it is ...
MannKind Corporation (NASDAQ:MNKD) Q4 2023 Earnings Call Transcript
As a reminder, this call is being recorded on February 27, 2024, and will be available for playback on the MannKind Corporation website shortly after the conclusion of the call until March 12, 2024.
Q4 2023 MannKind Corp Earnings Call
As a reminder, this call is being recorded on February 27, 2024, and will be available for playback on the MannKind Corporation website shortly after the conclusion of the call until March 12 ...
MannKind Corporation
MANNKIND CORP's gross profit margin for the fourth quarter of its fiscal year 2023 has significantly increased when compared to the same period a year ago. The company grew its sales and net ...
MannKind Corp MNKD
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...
MannKind Corporation (MNKD) Q4 2023 Earnings Call Transcript
Good afternoon and welcome to MannKind Corporation 2023 Fourth Quarter and Full Year Financial Results Earnings Call. As a reminder, this call is being recorded on February 27, 2024, and will be ...
MannKind Corp.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Q4 2023 MannKind Corp Earnings Call
As a reminder, this call is being recorded on February 27, 2024, and will be available for playback on the MannKind Corporation website shortly after the conclusion of the call until March 12, 2024 ...
Loading the latest forecasts...